Search results - 125 results
Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.
EU4H ealth Programme. Health Topics: Human papillomavirus (HPV) and cervical cancer Papillomavirus humain (PVH) et cancer du col de l'utérus Humaan papillomavirus (hpv) en baarmoederhalskanker ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
Kate; M. Arbyn Source: Journal of Medical Virology, Volume 95, Issue 1 (2023) Keywords: cervical cancer HPV genotyping human papillomavirus OncoPredict HPV® test validation. VALGENT Abstract: Human ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
Cuschieri, Kate; M. Arbyn Source: J Med Virol, Volume 95, Issue 1 (2023) Keywords: Early Detection of Cancer Female Genotyping Techniques Human Papillomavirus Viruses Humans Papillomaviridae Papillomavirus ...
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening
HPV SCREENING self-sampling self-sampling kits Abstract: BACKGROUND: Human papillomavirus (HPV) testing on self-samples represents a great opportunity to increase cervical cancer screening uptake among ...
HPV and head and neck cancers: Towards early diagnosis and prevention.
viral infections, such as the mucosal high-risk (HR) human papillomaviruses (HPV s) are major risk factors for HNSCC development. In particular, HR HPV s are mainly associated with a subset of ...
Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
HPV mRNA; Oropharyngeal carcinoma; HPV-AHEAD Abstract: Background The incidence of high-risk human papillomavirus (hrHPV)-driven head and neck squamous cell carcinoma, in particular oropharyngeal ...
Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework
clinically validated human papillomavirus (HPV) tests should be used in cervical cancer screening. VALGENT provides a framework to validate new HPV tests. In the VALGENT-3 study, the clinical accuracy of the ...
HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study
80 and over Alphapapillomavirus Belgium Cyclin-Dependent Kinase Inhibitor p16 DNA, Viral Female Genotype Head and Neck Neoplasms Head and neck neoplasms; Human papillomavirus; Human papillomavirus DNA ...
Cervical cancer screening using HPV tests on self-samples: attitudes and preferences of women participating in the VALHUDES study
Severien Van Keer; Alex Vorsters; M. Arbyn Source: Archives of Public Health, Volume 79, Issue 1 (2021) Keywords: ATTITUDES cervical cancer HPV human papillomavirus Preferences SCREENING self-sampling urine ...
Tackling cervical cancer in Europe amidst the COVID-19 pandemic.
estimates for 2018, approximately 33 000 cases of cervical cancer occurred and 15 000 people died from the disease in Europe (see map in appendix). Human papillomavirus (HPV) vaccine coverage is relatively ...